October Pharma S.A.E (EGX:OCPH)

Egypt · Delayed Price · Currency is EGP

240.00

0.00 (0.00%)

At close: Aug 5, 2026

October Pharma S.A.E Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '26 Aug 4, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	5,760	1,310	1,200	1,200	978	600
Market Cap Growth	265.13%	9.14%	0%	22.68%	63.02%	51.52%
Enterprise Value	6,117	1,817	1,518	1,257	1,193	853
Last Close Price	480.00	109.14	97.50	97.50	77.49	46.11

Price Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '26 Aug 4, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
PE Ratio	34.89	9.98	7.98	10.55	8.16	6.80
PS Ratio	3.94	1.07	1.19	1.65	1.49	1.10
PB Ratio	8.68	2.30	2.04	2.82	2.88	2.36
P/TBV Ratio	9.80	2.68	2.41	3.67	4.18	4.25
P/FCF Ratio	16.19	-	10.17	-	4.04	12.59
P/OCF Ratio	15.52	30.29	7.83	-	3.73	11.26

EV Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '26 Aug 4, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
EV/Sales Ratio	4.18	1.48	1.50	1.73	1.82	1.57
EV/EBITDA Ratio	14.58	5.19	4.61	5.68	5.52	5.20
EV/EBIT Ratio	16.14	5.67	4.94	6.31	6.10	5.88
EV/FCF Ratio	17.20	-	12.87	-	4.92	17.90

Financial Efficiency

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '26 Aug 4, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Debt / Equity Ratio	0.64	0.97	0.55	0.76	0.22	0.98
Debt / EBITDA Ratio	1.01	1.57	0.98	1.46	0.34	1.52
Debt / FCF Ratio	1.20	-	2.75	-	0.31	5.21
Net Debt / Equity Ratio	0.54	0.88	0.47	0.74	0.17	0.97
Net Debt / EBITDA Ratio	0.85	1.43	0.85	1.43	0.27	1.50
Net Debt / FCF Ratio	1.00	-50.91	2.36	-1.71	0.24	5.17
Asset Turnover	1.02	0.96	0.97	0.97	1.13	0.95
Inventory Turnover	2.37	2.89	2.45	1.78	2.15	2.55
Quick Ratio	0.47	0.39	0.56	0.36	0.75	0.31
Current Ratio	1.75	1.44	1.82	1.54	2.17	1.38
Return on Equity (ROE)	28.29%	26.20%	35.89%	34.18%	40.38%	40.64%
Return on Assets (ROA)	16.60%	15.70%	18.38%	16.57%	21.09%	15.84%
Return on Invested Capital (ROIC)	30.13%	24.76%	28.40%	26.38%	31.71%	24.55%
Return on Capital Employed (ROCE)	47.60%	47.00%	45.10%	37.90%	48.80%	44.50%

Yields

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '26 Aug 4, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Earnings Yield	2.87%	11.59%	15.18%	10.90%	12.25%	14.71%
FCF Yield	6.17%	-0.75%	9.83%	-15.42%	24.79%	7.94%
Dividend Yield	-	-	2.56%	-	-	3.25%
Payout Ratio	11.06%	36.54%	9.86%	34.16%	28.54%	16.83%
Total Shareholder Return	-	-	2.56%	-	-	3.25%